Leila Alland, Chief Medical Officer at PMV Pharmaceuticals, Inc. (PMVP), sold 8,000 shares at $32.66 ($258K) on 2021-07-07, disclosed to the SEC on 2021-07-08.
Open-market sale of $258k PMVP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.93 | 1,951 | $62K | 24.1% |
| 2 | $31.93 | 1,951 | $62K | 24.1% |
| 3 | $32.66 | 2,049 | $67K | 25.9% |
| 4 | $32.66 | 2,049 | $67K | 25.9% |
| Total | $32.30 avg | 8,000 | $258K | 100% |
| Filing → |
| ABEO | BUY | 2024-05-20 | $52K | — | Filing → |
| ABEO | SELL | 2023-09-29 | $28K | — | Filing → |
| PMVP | SELL | 2023-09-18 | $42K | — | Filing → |